PULSE BIOSCIENCES, INC. Quarterly Debt-to-equity in % from Q1 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Pulse Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q1 2018 to Q3 2024.
  • Pulse Biosciences, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 29.5 %, a 84.5% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 29.5 -160 -84.5% Sep 30, 2024
Q2 2024 34.4 -443 -92.8% Jun 30, 2024
Q1 2024 28.8 -1.53K -98.1% Mar 31, 2024
Q4 2023 84.6 -325 -79.4% Dec 31, 2023
Q3 2023 190 +50.2 +36% Sep 30, 2023
Q2 2023 477 +425 +821% Jun 30, 2023
Q1 2023 1.56K +1.51K +3542% Mar 31, 2023
Q4 2022 410 +343 +513% Dec 31, 2022
Q3 2022 139 +60.6 +76.8% Sep 30, 2022
Q2 2022 51.8 -33.5 -39.3% Jun 30, 2022
Q1 2022 42.7 -51.6 -54.7% Mar 31, 2022
Q4 2021 66.9 +15.5 +30.2% Dec 31, 2021
Q3 2021 78.9 +36.3 +85.2% Sep 30, 2021
Q2 2021 85.3 +52.2 +157% Jun 30, 2021
Q1 2021 94.3 +69.1 +274% Mar 31, 2021
Q4 2020 51.4 +34.6 +205% Dec 31, 2020
Q3 2020 42.6 +31.7 +291% Sep 30, 2020
Q2 2020 33.2 +23.1 +229% Jun 30, 2020
Q1 2020 25.2 +15.8 +167% Mar 31, 2020
Q4 2019 16.8 +6.78 +67.5% Dec 31, 2019
Q3 2019 10.9 -0.21 -1.89% Sep 30, 2019
Q2 2019 10.1 +0.65 +6.9% Jun 30, 2019
Q1 2019 9.43 -0.19 -1.98% Mar 31, 2019
Q4 2018 10.1 Dec 31, 2018
Q3 2018 11.1 Sep 30, 2018
Q2 2018 9.41 Jun 30, 2018
Q1 2018 9.62 Mar 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.